Sino Medical Sciences Technology Inc.
SSE:688108.SS
11.2 (CNY) • At close June 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 458.739 | 343.258 | 192.854 | 194.356 | 327.42 | 435.913 | 380.422 | 322.005 | 265.614 |
| Cost of Revenue
| 174.587 | 145.637 | 71.133 | 50.867 | 65.819 | 74.421 | 67.31 | 52.046 | 38.326 |
| Gross Profit
| 284.152 | 197.62 | 121.721 | 143.489 | 261.601 | 361.492 | 313.112 | 269.959 | 227.288 |
| Gross Profit Ratio
| 0.619 | 0.576 | 0.631 | 0.738 | 0.799 | 0.829 | 0.823 | 0.838 | 0.856 |
| Reseach & Development Expenses
| 140.557 | 114.095 | 152.797 | 148.933 | 108.735 | 89.593 | 66.548 | 53.676 | 75.997 |
| General & Administrative Expenses
| 30.171 | 30.797 | 28.154 | 25.255 | 18.823 | 19.681 | 20.49 | 59.764 | 35.457 |
| Selling & Marketing Expenses
| 29.704 | 63.199 | 55.232 | 57.99 | 77.365 | 105.501 | 87.55 | 70.284 | 71.715 |
| SG&A
| 59.875 | 156.361 | 83.386 | 83.246 | 96.188 | 125.181 | 108.04 | 130.048 | 107.172 |
| Other Expenses
| 100.686 | -3.419 | 85.549 | 67.382 | 43.017 | 43.803 | -5.638 | -1.809 | 2.345 |
| Operating Expenses
| 301.118 | 267.038 | 321.732 | 299.561 | 247.939 | 258.577 | 210.636 | 188.307 | 187.353 |
| Operating Income
| -16.966 | -69.135 | -200.011 | -156.072 | 15.362 | 108.583 | 108.335 | 82.345 | 38.014 |
| Operating Income Ratio
| -0.037 | -0.201 | -1.037 | -0.803 | 0.047 | 0.249 | 0.285 | 0.256 | 0.143 |
| Total Other Income Expenses Net
| -0.192 | -0.049 | -2.163 | 0.173 | 13.48 | -0.61 | -5.638 | -1.809 | 2.345 |
| Income Before Tax
| -17.158 | -69.184 | -221.34 | -163.103 | 28.842 | 107.973 | 102.697 | 80.537 | 40.359 |
| Income Before Tax Ratio
| -0.037 | -0.202 | -1.148 | -0.839 | 0.088 | 0.248 | 0.27 | 0.25 | 0.152 |
| Income Tax Expense
| -13.269 | -24.457 | -48.029 | -31.805 | 6.349 | 17.935 | 13.507 | 14.391 | 11.709 |
| Net Income
| 1.498 | -39.63 | -173.31 | -131.299 | 22.493 | 90.038 | 89.19 | 66.146 | 28.65 |
| Net Income Ratio
| 0.003 | -0.115 | -0.899 | -0.676 | 0.069 | 0.207 | 0.234 | 0.205 | 0.108 |
| EPS
| 0.004 | -0.1 | -0.42 | -0.32 | 0.055 | 0.22 | 0.25 | 0.29 | 0.14 |
| EPS Diluted
| 0.004 | -0.1 | -0.42 | -0.32 | 0.055 | 0.22 | 0.25 | 0.29 | 0.14 |
| EBITDA
| 66.617 | 3.314 | -139.79 | -95.493 | 50.208 | 142.719 | 123.201 | 99.325 | 53 |
| EBITDA Ratio
| 0.145 | 0.01 | -0.725 | -0.491 | 0.153 | 0.327 | 0.324 | 0.308 | 0.2 |